The evolving management of small renal masses

Stephen A. Boorjian, Robert G. Uzzo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The incidence of small renal masses (SRMs) continues to rise, largely because of the widespread use of cross-sectional imaging for abdominal symptomatology. Clinical management must balance the risk of disease progression from renal cell carcinoma in these tumors against the potential morbidity of treatment, particularly in elderly patients or those with multiple comorbidities. Moreover, a significant minority of SRMs represent benign lesions. This article reviews the current data for surgical excision, cryoablation, radiofrequency ablation, and active surveillance of SRMs. Surgical excision, predominantly in the form of nephron-sparing surgery, remains the standard of care because of its durable oncologic and favorable functional outcomes. Active surveillance and ablative technologies have emerged as alternatives to surgery in select patients based on short-term oncologic data. Nevertheless, the extent to which treatment alters the natural history of SRMs has yet to be established.

Original languageEnglish (US)
Pages (from-to)211-217
Number of pages7
JournalCurrent Oncology Reports
Volume11
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Kidney
Cryosurgery
Nephrons
Standard of Care
Natural History
Renal Cell Carcinoma
Disease Progression
Comorbidity
Technology
Morbidity
Incidence
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology

Cite this

The evolving management of small renal masses. / Boorjian, Stephen A.; Uzzo, Robert G.

In: Current Oncology Reports, Vol. 11, No. 3, 2009, p. 211-217.

Research output: Contribution to journalArticle

Boorjian, Stephen A. ; Uzzo, Robert G. / The evolving management of small renal masses. In: Current Oncology Reports. 2009 ; Vol. 11, No. 3. pp. 211-217.
@article{d932092ff4e74f418651da1e7926a8a3,
title = "The evolving management of small renal masses",
abstract = "The incidence of small renal masses (SRMs) continues to rise, largely because of the widespread use of cross-sectional imaging for abdominal symptomatology. Clinical management must balance the risk of disease progression from renal cell carcinoma in these tumors against the potential morbidity of treatment, particularly in elderly patients or those with multiple comorbidities. Moreover, a significant minority of SRMs represent benign lesions. This article reviews the current data for surgical excision, cryoablation, radiofrequency ablation, and active surveillance of SRMs. Surgical excision, predominantly in the form of nephron-sparing surgery, remains the standard of care because of its durable oncologic and favorable functional outcomes. Active surveillance and ablative technologies have emerged as alternatives to surgery in select patients based on short-term oncologic data. Nevertheless, the extent to which treatment alters the natural history of SRMs has yet to be established.",
author = "Boorjian, {Stephen A.} and Uzzo, {Robert G.}",
year = "2009",
doi = "10.1007/s11912-009-0030-6",
language = "English (US)",
volume = "11",
pages = "211--217",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "3",

}

TY - JOUR

T1 - The evolving management of small renal masses

AU - Boorjian, Stephen A.

AU - Uzzo, Robert G.

PY - 2009

Y1 - 2009

N2 - The incidence of small renal masses (SRMs) continues to rise, largely because of the widespread use of cross-sectional imaging for abdominal symptomatology. Clinical management must balance the risk of disease progression from renal cell carcinoma in these tumors against the potential morbidity of treatment, particularly in elderly patients or those with multiple comorbidities. Moreover, a significant minority of SRMs represent benign lesions. This article reviews the current data for surgical excision, cryoablation, radiofrequency ablation, and active surveillance of SRMs. Surgical excision, predominantly in the form of nephron-sparing surgery, remains the standard of care because of its durable oncologic and favorable functional outcomes. Active surveillance and ablative technologies have emerged as alternatives to surgery in select patients based on short-term oncologic data. Nevertheless, the extent to which treatment alters the natural history of SRMs has yet to be established.

AB - The incidence of small renal masses (SRMs) continues to rise, largely because of the widespread use of cross-sectional imaging for abdominal symptomatology. Clinical management must balance the risk of disease progression from renal cell carcinoma in these tumors against the potential morbidity of treatment, particularly in elderly patients or those with multiple comorbidities. Moreover, a significant minority of SRMs represent benign lesions. This article reviews the current data for surgical excision, cryoablation, radiofrequency ablation, and active surveillance of SRMs. Surgical excision, predominantly in the form of nephron-sparing surgery, remains the standard of care because of its durable oncologic and favorable functional outcomes. Active surveillance and ablative technologies have emerged as alternatives to surgery in select patients based on short-term oncologic data. Nevertheless, the extent to which treatment alters the natural history of SRMs has yet to be established.

UR - http://www.scopus.com/inward/record.url?scp=65349112451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65349112451&partnerID=8YFLogxK

U2 - 10.1007/s11912-009-0030-6

DO - 10.1007/s11912-009-0030-6

M3 - Article

C2 - 19336013

AN - SCOPUS:65349112451

VL - 11

SP - 211

EP - 217

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 3

ER -